Trivitron  ------Speaking your language
Welcome to Trivitron.com
speaking your language for over 10 Years.
Back to home. Learn more about our Products. Trivitron's News Room. Learn more about Trivitron. Career oppurtunities at Trivitron. Various Resources, Downloads etc. Keep in touch with us.
Browse Products by Category
Critical Care
Devices
Diagnostics
 
Clinical Chemistry
 
Lead Analysers
 
Electrophoresis
 
Immunodiagnostics
 
Haemotology / Pathology
 
Molecular Diagnostics & Microbiology
 
Point of Care Diagnostics
 
Blood Bank Products
 
Cytology
Imaging
Neurology
Renal Care
Surgical Technologies
Trivitech
Manufacturing
You are Here: Home > Products > Diagnostics > Point of Care Diagnostics

The ThinPrep Difference: Setting New Standards in Cervical Cancer Screening The ThinPrep Pap Test and the ThinPrep Imaging System combine to create more accurate and comprehensive cervical cancer screening — giving added confidence in the results. Furthermore, Dual Review screening, only available with the ThinPrep Imaging System, is taking cervical cancer screening to the next level.

Beyond the Conventional Pap Smear
The pap test is arguably the most successful cancer screening tool known today. Find out how the ThinPrep Pap Test took this test to the next level and became the only liquid-based pap test found to be "significantly more effective" than the conventional pap smear.

   

Diagnostic Superiority
Large, independent studies confirm that the ThinPrep Pap Test detects more disease. Clinical studies have also shown that the ThinPrep Imaging System with Dual Review provides additional disease detection over manually reviewed ThinPrep Pap Test slides.

   

Unique Among Liquid-Based Tests
All liquid-based technologies are not the same. Distinct differences backed by sound clinical data continue to make the ThinPrep Pap Test and the ThinPrep Imaging System the first choice of physicians.

   

FDA-Approved
The ThinPrep Pap Test is the only liquid-based pap test FDA-approved for HPV, Gonorrhea, and Chlamydia testing straight from the vial. Moreover, the ThinPrep Pap Test is the only pap test with FDA-approved labeling supported by multiple peer-reviewed publications showing increased glandular disease detection.1-6

   

Clinical and Independent
Studies Several clinical and independent studies have demonstrated the advantages and benefits of the ThinPrep Pap Test over the conventional pap smear, as well as the benefits of the ThinPrep Imaging System over manually reviewed ThinPrep Pap Test slides.

   

http://www.thinprep.com/hcp/thinprep_difference.html


References

1. Bai H, Sung CJ, Steinhoff MM. ThinPrep Pap Test promotes detection of glandular lesions of the endocervix. Diagn Cytopathol. 2000;23:19-22.
2. Carpenter AB, Davey DD. ThinPrep Pap Test: Performance biopsy follow-up in a university hospital. Cancer. 1999;87:105-12.
3. Guidos BJ, Selvaggi SM. Detection of endometrial adenocarcinoma with the ThinPrep Pap Test. Diagn Cytopathol. 2000;23:260-5.
4. Schorge JO, Hossein Saboorian M, Hynan L, et al. ThinPrep detection of endometrial adenocarcinoma: a retrospective cohort study. Cancer Cytopathol. 2002;96:338-43.
5. Wang N, Emancipator SN, Rose P, et al. Histologic follow-up of atypical endocervical cells: liquid-based, thin-layer preparation vs. conventional Pap smear. Acta Cytol. 2002;46:453-7.
6. Ashfaq R, Gibbons D, Vela C, Saboorian MH, Iliya F. ThinPrep Pap Test accuracy for glandular disease. Acta Cytol. 1999;43:81-5.

<< Back
Next >>
Products | News and Events | Careers | About Trivitron Healthcare
| Media Center | Contact | Terms of use | Privacy Policy